INSIGHTS ON PHARMACEUTICAL INSPECTION

PHARMACEUTICAL INSPECTION SOLUTIONS

  • A missing or cocked cap on a product package can result in unnecessary product waste and costly rework, which leads to lost profits. Our systems can quickly identify products with missing or improperly-applied caps, removing them from the production line and alerting operators to the issue.

  • As part of Stevanato Group’s commitment to R&D, our analytical testing facilities focus on investigating physico-chemical properties of primary packaging materials and components and studying the interactions between container closure system and drugs. Stevanato Group relies on a multi-disciplinary team of highly skilled professionals, including, scientists, engineers, pharmaceutical chemists and biotechnologists. Their knowledge and experience covers a range of specialized areas including container closure systems and drug-delivery devices.

  • The VeriPac 465 performs leak detection based on the basic principles of physics and does not require the use of trace gasses or sample preparation to perform the test. The VeriPac 465 core technology is based on the ASTM vacuum decay leak test method (F2338) recognized by the FDA as a consensus standard for package integrity testing. This test method was developed using VeriPac leak test instruments.

  • Referenced in the new USP <1207> Chapter Guidance as a deterministic test method for container closure integrity testing.

  • With our Switch 350, you benefit from the advantages of two machine concepts: We have combined the modularity, handling options, and technologies of our well-proven standard platforms with the flexibility of our small batch inspection machine to run syringes and vials on one and the same machine – with nesting system for syringes and vials alike.